Prognostic and therapeutic implications of distinct kinase expression patterns in different subtypes of breast cancer.
about
Prediction of adjuvant chemotherapy response in triple negative breast cancer with discovery and targeted proteomics.A personalized committee classification approach to improving prediction of breast cancer metastasis.The mechanistic target for rapamycin pathway is related to the phosphorylation score for estrogen receptor-α in human breast tumors in vivo.Development of an orally-administrative MELK-targeting inhibitor that suppresses the growth of various types of human cancer.Comprehensive Two- and Three-Dimensional RNAi Screening Identifies PI3K Inhibition as a Complement to MEK Inhibitor AS703026 for Combination Treatment of Triple-Negative Breast Cancer.Characterization of DNA variants in the human kinome in breast cancer.DNA repair gene patterns as prognostic and predictive factors in molecular breast cancer subtypes.Inhibition of the PI3K/AKT pathway potentiates cytotoxicity of EGFR kinase inhibitors in triple-negative breast cancer cells.Proliferation and estrogen signaling can distinguish patients at risk for early versus late relapse among estrogen receptor positive breast cancersMELK: a potential novel therapeutic target for TNBC and other aggressive malignancies.TP53 mutation-correlated genes predict the risk of tumor relapse and identify MPS1 as a potential therapeutic kinase in TP53-mutated breast cancers.Immune modulation of pathologic complete response after neoadjuvant HER2-directed therapies in the NeoSphere trial.Subtype-dependent prognostic relevance of an interferon-induced pathway metagene in node-negative breast cancer.Prognostic and functional role of subtype-specific tumor-stroma interaction in breast cancer.Prognostic immune-related gene models for breast cancer: a pooled analysis.Interactions between the tumor and the blood systemic response of breast cancer patients.Estrogen receptor (ER) mRNA expression and molecular subtype distribution in ER-negative/progesterone receptor-positive breast cancers.Prognostic evaluation of the B cell/IL-8 metagene in different intrinsic breast cancer subtypes.Immunohistochemical Ki67 labeling index has similar proliferation predictive power to various gene signatures in breast cancer.Gene pathways associated with prognosis and chemotherapy sensitivity in different molecular subtypes of breast cancer.Tumour-infiltrating lymphocytes (TILs)-related genomic signature predicts chemotherapy response in breast cancer.BCDForest: a boosting cascade deep forest model towards the classification of cancer subtypes based on gene expression data.CSF-1/CSF-1R axis is associated with epithelial/mesenchymal hybrid phenotype in epithelial-like inflammatory breast cancer.
P2860
Q33778306-64FB1A52-E389-4C18-B4FE-0EB16E629455Q33807643-45378204-284D-4D4F-94EA-143B68068BE8Q33827011-D5A6E1C5-3D83-4817-B9F1-336A5594C15EQ34530885-39C48E7C-3F41-4CD8-8171-451373B7AD86Q35861891-0561D4F2-714A-4066-90E1-2AFCBFF3DF74Q36106656-DC032E1F-BD61-42F4-8A1B-F204FBDCF130Q37247163-EDB0E8C5-F347-4903-9128-C8BB22289581Q37294562-2F3B8BD7-1C5C-401F-9D9F-41AC5C9AC2BEQ37690351-A0FB112C-DB4E-4A89-BFB5-865D5496C06EQ38648606-CCEDC4AB-7297-4B32-90F1-423014D505AEQ39030842-48D7C3B1-C066-46B1-87BA-7DED1596BB94Q40521722-41B9120D-077C-4A17-ACC0-C25EB6CB3894Q41135122-4DF04153-3982-46A9-A852-2D337B6252EEQ41880628-311C8299-939B-48BF-BD31-9320A933B711Q42001306-26756CC8-4BDF-480F-A900-5EF71630A63CQ42366134-337DA41B-7264-414F-B47D-7418AB256C91Q42450983-9AD7CDC7-14BB-4C93-8145-58F3A7FE5058Q42517986-EF99C7C2-5363-4069-9F91-679D4F2CED9EQ45912156-519DF4D6-939A-4537-9B8B-05A01E5DFB58Q46131859-92D41477-A1CF-4DA0-AC3C-FF1E9C6424CEQ47988029-A60CBBF6-AB00-4A3F-9E83-3D06C11C12E1Q52578595-4578144D-4A76-4C4E-9276-53348917E78BQ55322297-9C652232-154D-4ADF-ACC9-ABB14AE6BD84
P2860
Prognostic and therapeutic implications of distinct kinase expression patterns in different subtypes of breast cancer.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Prognostic and therapeutic imp ...... ent subtypes of breast cancer.
@en
Prognostic and therapeutic imp ...... ent subtypes of breast cancer.
@nl
type
label
Prognostic and therapeutic imp ...... ent subtypes of breast cancer.
@en
Prognostic and therapeutic imp ...... ent subtypes of breast cancer.
@nl
prefLabel
Prognostic and therapeutic imp ...... ent subtypes of breast cancer.
@en
Prognostic and therapeutic imp ...... ent subtypes of breast cancer.
@nl
P2093
P1433
P1476
Prognostic and therapeutic imp ...... ent subtypes of breast cancer.
@en
P2093
Bailang Wang
Charles Coutant
Christine Y Shiang
Gabriel N Hortobagyi
Giampaolo Bianchini
Lajos Pusztai
Luca Gianni
Takayuki Iwamoto
Vicente Valero
W Fraser Symmans
P304
P356
10.1158/0008-5472.CAN-10-1039
P407
P577
2010-10-19T00:00:00Z